Increased expression of MYO5A has been observed in several metastatic cell lines, including metastatic colorectal, lung, breast, and prostate cancers, as well as in invasive and metastatic esophageal squamous cell carcinomas [41, 42]. The gene discussed is MYO5A; the disease is prostate carcinoma.